A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)

PHASE2CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 18, 2014

Study Completion Date

March 18, 2014

Conditions
Cystitis, InterstitialUrinary Bladder DiseasePainUrologic Diseases
Interventions
DRUG

ASP3652

Oral

DRUG

Placebo

Oral

Trial Locations (60)

1002

Site: 5601, Riga

1038

Site: 5603, Riga

1070

Site: 5103, Brussels

2650

Site: 5101, Antwerp

2730

Site: 5301, Herlev

3401

Site: 5602, Liepāja

4700

Site: 5302, Næstved

8200

Site: 5303, Aarhus

10207

Site: 6303, Vilnius

29009

Site 6204, Málaga

37603

Site: 5402, Holzminden

38330

Site 6202, Laguna

47179

Site: 5406, Duisburg

50154

Site: 6304, Kaunas

55131

Site: 5405, Mainz

60590

Site: 5409, Frankfurt am Main

72622

Site: 5404, Nürtingen

73270

Site 5410, Kirchheim

77654

Site: 5414, Offenburg

79312

Site: 5403, Emmendingen

101000

Site 6108, Moscow

105425

Site 6103, Moscow

115682

Site: 6111, Moscow

117997

Site 6106, Moscow

127473

Site 6101, Moscow

197022

Site 6102, Saint Petersburg

500152

Site 6006, Brasov

540103

Site 6001, Târgu Mureş

700503

Site 6005, Iași

500 05

Site: 5202, Kralove

767 55

Site: 5203, Kroměříž

775 20

Site: 5206, Olomouc

301 00

Site: 5209, Pilsen

785 01

Site: 5210, Sternberk

686 68

Site: 5201, Uherské Hradiště

08661

Site: 6302, Vilnius

09108

Site: 6301, Vilnius

1081HV

Site: 5706, Amsterdam

6229 HX

Site: 5703, Maastricht

6525 GA

Site: 5701, Nijmegen

7101 BN

Site: 5702, Winterswijk

3331 LZ

Site: 5704, Zwijndrecht

15-224

Site: 5807, Bialystok

85-094

Site 5806, Bydgoszcz

41-500

Site: 5811, Chorzów

90-447

Site: 5801, Lodz

05-500

Site: 5805, Piaseczno

61-397

Site: 5812, Poznan

00-865

Site: 5802, Warsaw

01-432

Site: 5804, Warsaw

02-784

Site: 5803, Warsaw

3000-075

Site 5902, Coimbra

4099-001

Site 5903, Porto

4200-319

Site 5901, Porto

0100-000

Site 6003, Bucharest

021392

Site 6004, Bucharest

022328

Site 6007, Bucharest

042122

Site 6002, Bucharest

08024

Site 6203, Barcelona

08850

Site 6201, Barcelona

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01613586 - A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) | Biotech Hunter | Biotech Hunter